LTC2049079I2 - Kompozicijos, turinčios ketvirtinio amonio junginį - Google Patents

Kompozicijos, turinčios ketvirtinio amonio junginį

Info

Publication number
LTC2049079I2
LTC2049079I2 LTPA2017003C LTPA2017003C LTC2049079I2 LT C2049079 I2 LTC2049079 I2 LT C2049079I2 LT PA2017003 C LTPA2017003 C LT PA2017003C LT PA2017003 C LTPA2017003 C LT PA2017003C LT C2049079 I2 LTC2049079 I2 LT C2049079I2
Authority
LT
Lithuania
Prior art keywords
quaternary ammonium
compositions containing
ammonium compound
compound
compositions
Prior art date
Application number
LTPA2017003C
Other languages
English (en)
Original Assignee
Santen Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=65014357&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTC2049079(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP06291236.5A external-priority patent/EP1891939B1/en
Priority claimed from US11/494,493 external-priority patent/US20080026013A1/en
Application filed by Santen Sas filed Critical Santen Sas
Publication of LTPA2017003I1 publication Critical patent/LTPA2017003I1/lt
Publication of LTC2049079I2 publication Critical patent/LTC2049079I2/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
    • A61L12/143—Quaternary ammonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/62—Quaternary ammonium compounds
    • C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LTPA2017003C 2006-07-28 2017-02-15 Kompozicijos, turinčios ketvirtinio amonio junginį LTC2049079I2 (lt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP06291236.5A EP1891939B1 (en) 2006-07-28 2006-07-28 Compositions containing quaternary ammonium compounds
US11/494,493 US20080026013A1 (en) 2006-07-28 2006-07-28 Compositions containing quaternary ammonium compounds
EP07112097 2007-07-09
PCT/IB2007/053441 WO2008035246A2 (en) 2006-07-28 2007-07-10 Compositions containing quaternary ammonium compounds
EP07787998.9A EP2049079B1 (en) 2006-07-28 2007-07-27 Compositions containing quaternary ammonium compounds
PCT/EP2007/057784 WO2008012367A2 (en) 2006-07-28 2007-07-27 Compositions containing quaternary ammonium compounds

Publications (2)

Publication Number Publication Date
LTPA2017003I1 LTPA2017003I1 (lt) 2017-03-10
LTC2049079I2 true LTC2049079I2 (lt) 2019-12-27

Family

ID=65014357

Family Applications (2)

Application Number Title Priority Date Filing Date
LTEP07787998.9T LT2049079T (lt) 2006-07-28 2007-07-27 Kompozicijos, turinčios ketvirtinio amonio junginį
LTPA2017003C LTC2049079I2 (lt) 2006-07-28 2017-02-15 Kompozicijos, turinčios ketvirtinio amonio junginį

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTEP07787998.9T LT2049079T (lt) 2006-07-28 2007-07-27 Kompozicijos, turinčios ketvirtinio amonio junginį

Country Status (17)

Country Link
US (7) US7973081B2 (lt)
EP (2) EP2404593B1 (lt)
JP (1) JP5441058B2 (lt)
KR (2) KR101507465B1 (lt)
AU (1) AU2007278141B2 (lt)
CA (1) CA2659322C (lt)
CY (3) CY1118148T1 (lt)
DK (2) DK2404593T3 (lt)
ES (2) ES2586381T3 (lt)
HU (2) HUE030841T2 (lt)
IL (2) IL196740A (lt)
LT (2) LT2049079T (lt)
LU (1) LUC00006I2 (lt)
PL (2) PL2049079T3 (lt)
PT (2) PT2404593T (lt)
SI (2) SI2049079T1 (lt)
WO (2) WO2008035246A2 (lt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2916636B1 (fr) * 2007-05-29 2009-09-04 Octalia Technologies Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
US20090298956A1 (en) * 2008-05-28 2009-12-03 Chowhan Masood A Self-preserved emulsions
EP2228057A1 (en) * 2009-03-04 2010-09-15 Novagali Pharma S.A. Cationic oil-in-water emulsions containing prostaglandins and uses thereof
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
MX2011011619A (es) * 2009-05-01 2012-02-28 Signal Invest And Man Co Composicion antimicrobiana hidratante.
MX358504B (es) 2009-06-05 2018-08-21 Allergan Inc Lagrimas artificiales y usos terapeuticos.
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
WO2013098841A1 (en) * 2011-10-31 2013-07-04 Fdc Limited Nanodispersion of poorly water soluble drug(s)
ES2797650T3 (es) * 2011-12-07 2020-12-03 Allergan Inc Administración de lípido eficiente a película lagrimal humana usando un sistema de emulsión sensible a sal
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
CA2947274C (en) * 2014-04-28 2019-03-19 Hampton Technologies Ophthalmic compositions and methods for treating eyes
US20160074178A1 (en) * 2014-09-17 2016-03-17 Van Phillips METHODS FOR PREPARING PRECISELY FITTED CASTS for PROSTHETICS
EP3011959A1 (en) * 2014-10-23 2016-04-27 Santen SAS Quaternary ammonium compound for use as an inhibitor of protein kinase C alpha
JP6768653B2 (ja) 2014-11-25 2020-10-14 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 安定したオメガ−３眼科用組成物
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
PT3266446T (pt) * 2016-07-07 2019-01-30 Salvat Lab Sa Composição oftálmica compreendendo óleo de rícino e triglicérido de cadeia média
ES3012007T3 (en) * 2020-09-18 2025-04-08 Omnivision Gmbh Lipid-based ophthalmic composition for the treatment of dry eye
EP4241761A4 (en) 2020-11-09 2024-09-25 Scai Therapeutics Co., Ltd. CYCLOSPORINE A SOLID AND DISPERSION COMPOSITION COMPRISING SAME
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US20240009124A1 (en) * 2022-07-05 2024-01-11 Primera Compounding, LLC Ophthalmic Suspension Base having a Micro-fluidized Positively Charged Nanoparticle
KR20250073671A (ko) * 2022-09-28 2025-05-27 폴라로이드 아이피 비.브이. 항균 코팅 조성물
US12600925B2 (en) 2023-04-21 2026-04-14 Reckitt Benckiser Llc Laundry sanitizing and softening compositions
WO2024226686A2 (en) * 2023-04-24 2024-10-31 Emory University Aminoadipate-semialdehyde synthase inhibitors and methods of treating cancer
TR2023007877A2 (tr) * 2023-07-06 2023-10-23 Ardi Farma Ilac Pazarlama Ticaret Ltd Sirketi Stabi̇l çoklu doz si̇klospori̇n yağ i̇çi̇nde su emülsi̇yon kompozi̇syonlari

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB633175A (en) * 1946-09-03 1949-12-12 Parke Davis & Co Antibiotic preparations and process for obtaining the same
USB724600I5 (lt) * 1968-04-26
AU499860B2 (en) 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
FR2648462B1 (fr) 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
JPH05116286A (ja) 1991-10-25 1993-05-14 Matsushita Electric Ind Co Ltd インク吐出装置
IL101241A (en) 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
IL103907A0 (en) * 1992-11-27 1993-04-04 Pharmos Corp Ophthalmic compositions
EP0656779B1 (en) 1992-08-28 2000-04-12 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
US5951988A (en) * 1993-03-30 1999-09-14 University Of Saskatchewan Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods
EP0631770B1 (en) 1993-06-25 1998-07-22 Alcon Cusi, S.A. New use of polymeric membranes in the dispensing of pharmaceutical solutions that contain quaternary ammonium compounds as preservatives and corresponding dose dispensor
ATE227114T1 (de) * 1993-08-30 2002-11-15 Unilever Nv Haarwasch- und konditionierungsmittel
JPH10500687A (ja) * 1994-05-20 1998-01-20 ノババックス インコーポレイテッド 抗菌性水中油エマルジョン
US5547990A (en) * 1994-05-20 1996-08-20 Lonza, Inc. Disinfectants and sanitizers with reduced eye irritation potential
US5435998A (en) * 1994-08-03 1995-07-25 Abelson; Mark B. Treatment of low-tension glaucoma by topical administration of calcium channel blocking agents
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5767153A (en) 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions
TW446563B (en) * 1996-01-16 2001-07-21 Colgate Palmolive Co Low static conditioning shampoo
US6071904A (en) 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
DE69807281T2 (de) 1997-05-14 2003-04-17 Mitsubishi Chemical Corp., Tokio/Tokyo Difluprednat enthaltende Zusammensetzungen
US20020169138A1 (en) * 1997-10-24 2002-11-14 Southern Research Institute Delivery vehicles for bioactive agents and uses thereof
WO1999051763A1 (en) 1998-04-02 1999-10-14 The Schepens Eye Research Institute, Inc. Corneal organ culture system for chemical toxicity tests of consumer products
FR2780879B1 (fr) * 1998-07-09 2002-09-20 Oreal Composition cosmetique photoprotectrice contenant un tensio-actif anionique, un compose filtrant le rayonnement ultraviolet et un compose cationique ou zwitterionique amphiphile et son utilisation
JP2003517441A (ja) * 1998-09-25 2003-05-27 アルコン ラボラトリーズ， インコーポレイテッド 徐放性で快適な眼疾病用組成物および眼疾病の治療方法
US6030789A (en) 1999-03-10 2000-02-29 The Gillette Company Human conjunctival epithelial cell lines with an extended life span
US6635676B2 (en) 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
JP2003510263A (ja) * 1999-09-24 2003-03-18 アルコン，インコーポレイテッド シプロフロキサシンおよびデキサメタゾンを含有する局所用懸濁処方物
EP1142566B1 (fr) 2000-04-07 2003-10-01 Laboratoire Medidom S.A. Formulations ophtalmiques à base de ciclosporine, d'acide hyaluronique et du polysorbate
AU2002314847A1 (en) * 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
JP2006512401A (ja) 2001-06-05 2006-04-13 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ナノエマルジョンワクチン
US6872705B2 (en) 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
ATE468107T1 (de) 2001-11-01 2010-06-15 Yissum Res Dev Co Verfahren und zusammensetzung zur behandlung von trockenen augen
US6656460B2 (en) * 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
WO2003080027A1 (en) 2002-03-20 2003-10-02 Elan Pharma International, Ltd. Nanoparticulate compositions of angiogenesis inhibitors
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
JP5382972B2 (ja) 2003-12-26 2014-01-08 ロート製薬株式会社 粘度低下が防止された組成物
US20050175651A1 (en) 2004-01-09 2005-08-11 L'oreal Aqueous dispersion of nanocapsules with an oily core
US20050158349A1 (en) 2004-01-20 2005-07-21 Jampani Hanuman B. Two-phase compositions containing alcohol
EP1611879B1 (en) 2004-07-02 2009-08-12 Novagali Pharma SA Use of emulsions for intra- and periocular injection
AU2005304035B2 (en) 2004-11-09 2010-07-22 Santen Sas Ophthalmic oil-in-water type emulsion with stable positive zeta potential
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
US20070231406A1 (en) 2006-01-30 2007-10-04 Bucalo Louis R Use of gallium to treat biofilm-associated infections
US20080026013A1 (en) 2006-07-28 2008-01-31 Laura Rabinovich-Guilatt Compositions containing quaternary ammonium compounds
US20090018057A1 (en) * 2007-07-09 2009-01-15 Gregory Lambert OIL IN WATER EMULSION COMPRISING NSAIDs AND QUATERNARY AMMONIUM HALIDES

Also Published As

Publication number Publication date
WO2008035246A3 (en) 2008-06-26
WO2008012367A3 (en) 2008-05-29
US11612658B2 (en) 2023-03-28
AU2007278141A1 (en) 2008-01-31
PL2049079T3 (pl) 2017-03-31
US20200000924A9 (en) 2020-01-02
KR101507097B1 (ko) 2015-03-31
HUE030841T2 (en) 2017-06-28
US10842873B2 (en) 2020-11-24
CY2017007I2 (el) 2017-06-28
DK2404593T3 (en) 2016-08-29
KR20090047496A (ko) 2009-05-12
IL241753A0 (en) 2015-11-30
US20110201689A1 (en) 2011-08-18
US20190022231A1 (en) 2019-01-24
PT2404593T (pt) 2016-08-16
US9956289B2 (en) 2018-05-01
EP2404593A1 (en) 2012-01-11
EP2049079A2 (en) 2009-04-22
CA2659322A1 (en) 2008-01-31
KR101507465B1 (ko) 2015-03-31
CA2659322C (en) 2014-07-15
IL196740A0 (en) 2009-11-18
US20080026991A1 (en) 2008-01-31
WO2008012367A2 (en) 2008-01-31
JP2009544667A (ja) 2009-12-17
ES2586381T3 (es) 2016-10-14
IL196740A (en) 2015-10-29
IL241753B (en) 2018-03-29
US8524779B2 (en) 2013-09-03
US7973081B2 (en) 2011-07-05
EP2049079B1 (en) 2016-09-07
SI2049079T1 (sl) 2017-03-31
WO2008035246A2 (en) 2008-03-27
LUC00006I2 (lt) 2017-05-02
LUC00006I1 (lt) 2017-02-28
LT2049079T (lt) 2016-12-12
KR20140041845A (ko) 2014-04-04
US20230181738A1 (en) 2023-06-15
HK1165993A1 (en) 2012-10-19
PL2404593T3 (pl) 2016-11-30
AU2007278141B2 (en) 2014-01-16
US9220694B2 (en) 2015-12-29
ES2606467T3 (es) 2017-03-24
US20130337019A1 (en) 2013-12-19
EP2404593B1 (en) 2016-05-11
CY1118436T1 (el) 2017-06-28
US20160082107A1 (en) 2016-03-24
LTPA2017003I1 (lt) 2017-03-10
DK2049079T3 (da) 2017-01-02
CY1118148T1 (el) 2017-06-28
SI2404593T1 (sl) 2016-11-30
PT2049079T (pt) 2016-12-09
JP5441058B2 (ja) 2014-03-12
US20210038721A1 (en) 2021-02-11
HUE029987T2 (en) 2017-04-28
CY2017007I1 (el) 2017-06-28

Similar Documents

Publication Publication Date Title
LTC2049079I2 (lt) Kompozicijos, turinčios ketvirtinio amonio junginį
LTPA2020501I1 (lt) Pakeistieji enaminokarbonilo junginiai
FR19C1035I2 (fr) Compositions fungicidal
EP2123654A4 (en) pyrazolopyrimidine compound
EP1985620A4 (en) 10a-azalide compound
EP2036901A4 (en) C-phenyl 1-thioglucitol compound
ATE552254T1 (de) Trisubstituierte aminverbindung
DK3275965T3 (da) Sammensætninger, der omfatter en fluorolefin
PL2094087T3 (pl) Kompozycje pestycydowe
EP1865958A4 (en) PHARMACOKINETICALLY IMPROVED COMPOUNDS
HUS1700007I1 (hu) Kvaterner ammónium vegyületeket tartalmazó készítmények
DK2414459T3 (da) Asfalt-mineral-sammensætninger, der indeholder en kationisk organosiliciumforbindelse
BRPI0811189A2 (pt) Ferramenta de nivelação composta.
CR10353A (es) Nuevos compuestos.
TWI370130B (en) Two cyclic cinnamide compound
DE602006017080D1 (de) Einer verpackung
EP1876179A4 (en) THIENOPYRIMIDONVERBINDUNGEN
EP1961741A4 (en) m-CARBAZOLYLPHENYLVERBINDUNGEN
EP2124549A4 (en) ANTIHYPERCHOLESTERINAMIC COMPOUNDS
EP2206749A4 (en) phthalocyanine
EP2098507A4 (en) CYCLIC AMINE COMPOUND
DK1891939T3 (da) Sammensætninger indeholdende kvaternære ammoniumforbindelser
ATE552240T1 (de) Cyclische aminverbindung
ATE473232T1 (de) Carbapenemdverbindung
ITBG20050002A1 (it) Macchina spremitrice per sansa di olive